The RB tumor suppressor: a gatekeeper to hormone independence in prostate cancer?

J Clin Invest. 2010 Dec;120(12):4179-82. doi: 10.1172/JCI45406. Epub 2010 Nov 22.

Abstract

The retinoblastoma tumor suppressor gene (RB1; encoding RB) is often cited as a gatekeeper, whose inactivation - direct or indirect - is a rate-limiting step for tumor initiation. However, in this issue of the JCI, Sharma et al. show that RB1 loss is a late event in human prostate cancer that is coincident with the emergence of castrate-resistant metastatic disease. This role for RB1 was linked to both E2F transcription factor 1-driven upregulation of the androgen receptor (AR) and increased recruitment of the AR to target gene promoters. This unexpected function for RB1 in late-stage cancer calls upon us to reassess the significance of RB1 inactivation in other cancers in terms of its timing, function in disease etiology, and relevance for cancer therapy.

Publication types

  • Comment
  • Research Support, N.I.H., Extramural

MeSH terms

  • E2F1 Transcription Factor / physiology
  • Genes, Retinoblastoma*
  • Humans
  • Male
  • Models, Biological
  • Orchiectomy
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / physiopathology*
  • Prostatic Neoplasms / therapy
  • Receptors, Androgen / physiology
  • Retinoblastoma Protein / physiology

Substances

  • AR protein, human
  • E2F1 Transcription Factor
  • E2F1 protein, human
  • Receptors, Androgen
  • Retinoblastoma Protein